Email ID
Password
Sign me in automatically next time
Scrip Regulatory Affairs
NBOG focus turns to notified body role in new and revised regulations
01 June 2010
Amanda Maxwell

Following the publication of a number of key documents related to how notified bodies should audit their medical device clients1, the European Commission’s Notified Bodies Operations Group is now anticipating the planned revision of the In Vitro Diagnostics Directive (Directive 98/79/EC)2...

Please login to read the full article.
 
 
 
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
   
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36